These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32050042)

  • 1. Absolute and relative differential blood count predicts survival of AJCC stage I-II melanoma patients scheduled for sentinel lymph node biopsy.
    Wagner NB; Luttermann F; Gassenmaier M; Forschner A; Leiter U; Garbe C; Eigentler TK
    Australas J Dermatol; 2020 Aug; 61(3):e310-e318. PubMed ID: 32050042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial.
    Schmidt H; Suciu S; Punt CJ; Gore M; Kruit W; Patel P; Lienard D; von der Maase H; Eggermont AM; Keilholz U; ;
    J Clin Oncol; 2007 Apr; 25(12):1562-9. PubMed ID: 17443000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basal neutrophil-to-lymphocyte ratio is associated with overall survival in melanoma.
    Lino-Silva LS; Salcedo-Hernández RA; García-Pérez L; Meneses-García A; Zepeda-Najar C
    Melanoma Res; 2017 Apr; 27(2):140-144. PubMed ID: 28125448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neutrophil-lymphocyte ratio and locoregional melanoma: a multicentre cohort study.
    Robinson AV; Keeble C; Lo MCI; Thornton O; Peach H; Moncrieff MDS; Dewar DJ; Wade RG
    Cancer Immunol Immunother; 2020 Apr; 69(4):559-568. PubMed ID: 31974724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic role of the preoperative absolute lymphocyte count and absolute monocyte count in patients with resected advanced melanoma.
    Rochet NM; Kottschade LA; Grotz TE; Porrata LF; Markovic SN
    Am J Clin Oncol; 2015 Jun; 38(3):252-8. PubMed ID: 23774073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel lymph node biopsy is indicated for patients with thick clinically lymph node-negative melanoma.
    Yamamoto M; Fisher KJ; Wong JY; Koscso JM; Konstantinovic MA; Govsyeyev N; Messina JL; Sarnaik AA; Cruse CW; Gonzalez RJ; Sondak VK; Zager JS
    Cancer; 2015 May; 121(10):1628-36. PubMed ID: 25677366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab.
    Capone M; Giannarelli D; Mallardo D; Madonna G; Festino L; Grimaldi AM; Vanella V; Simeone E; Paone M; Palmieri G; Cavalcanti E; Caracò C; Ascierto PA
    J Immunother Cancer; 2018 Jul; 6(1):74. PubMed ID: 30012216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Value of the Neutrophil-to-lymphocyte Ratio, Platelet-to- lymphocyte Ratio and Monocyte-to-lymphocyte Ratio in Melanoma Patients: A Cohort Study.
    Ertekin SS; Mangas C; Riquelme-Mc Loughlin C; Carrera C; Malvehy J; Puig S; Podlipnik S
    Acta Derm Venereol; 2024 Apr; 104():adv27571. PubMed ID: 38655656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sentinel lymph node biopsy status is a key parameter to stratify the prognostic heterogeneity of malignant melanoma in high-risk tumors >4.0 mm.
    Göppner D; Ulrich J; Pokrywka A; Peters B; Gollnick H; Leverkus M
    Dermatology; 2011 Feb; 222(1):59-66. PubMed ID: 21196701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood Predictive Biomarkers for Nivolumab in Advanced Melanoma.
    Chasseuil E; Saint-Jean M; Chasseuil H; Peuvrel L; Quéreux G; Nguyen JM; Gaultier A; Varey E; Khammari A; Dréno B
    Acta Derm Venereol; 2018 Apr; 98(4):406-410. PubMed ID: 29327065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of time to sentinel lymph node biopsy on cutaneous melanoma survival.
    Fortes C; Mastroeni S; Caggiati A; Passarelli F; Zappalà A; Capuano M; Bono R; Nudo M; Marino C; Michelozzi P
    Am J Surg; 2016 Nov; 212(5):935-940. PubMed ID: 27266393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impacts of pretreatment circulating eosinophils and basophils on prognosis of stage Ⅰ-Ⅲ colorectal cancer.
    Wei Y; Zhang X; Wang G; Zhou Y; Luo M; Wang S; Hong C
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e243-e251. PubMed ID: 29532611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.
    Nowecki ZI; Rutkowski P; Kulik J; Siedlecki JA; Ruka W
    Br J Dermatol; 2008 Sep; 159(3):597-605. PubMed ID: 18616789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of the AJCC 7th edition change in T1 melanoma substaging on national utilization and outcomes of sentinel lymph node biopsy for thin melanoma.
    Hieken TJ; Grotz TE; Comfere NI; Inselman JW; Habermann EB
    Melanoma Res; 2015 Apr; 25(2):157-63. PubMed ID: 25647736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic role of sentinel lymph node biopsy for patients with cutaneous melanoma: A retrospective study of surveillance, epidemiology, and end-result population-based data.
    Chen J; Xu Y; Zhou Y; Wang Y; Zhu H; Shi Y
    Oncotarget; 2016 Jul; 7(29):45671-45677. PubMed ID: 27344178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel Lymph Node Biopsy in T4 Melanoma: An Important Risk-Stratification Tool.
    Gyorki DE; Sanelli A; Herschtal A; Lazarakis S; McArthur GA; Speakman D; Spillane J; Henderson MA
    Ann Surg Oncol; 2016 Feb; 23(2):579-84. PubMed ID: 26471491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel lymph node biopsy in thick malignant melanoma: a 10-year single unit experience.
    Fairbairn NG; Orfaniotis G; Butterworth M
    J Plast Reconstr Aesthet Surg; 2012 Oct; 65(10):1396-402. PubMed ID: 22552263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis of sentinel node staged patients with primary cutaneous melanoma.
    Elsaesser O; Leiter U; Buettner PG; Eigentler TK; Meier F; Weide B; Metzler G; Breuninger H; Garbe C
    PLoS One; 2012; 7(1):e29791. PubMed ID: 22276129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Prognostic Significance of Sentinel Lymph Node Status for Patients with Thick Melanoma.
    Bello DM; Han G; Jackson L; Bulloch K; Ariyan S; Narayan D; Rothberg BG; Han D
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):938-945. PubMed ID: 27527717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel lymph node biopsy in thick malignant melanoma: A 16-year single unit experience.
    Hunger RE; Michel A; Seyed Jafari SM; Shafighi M
    Eur J Dermatol; 2015; 25(5):472-6. PubMed ID: 26394835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.